GFBiochemicals enters USA market

30 March 2016

GFBiochemicals, the largest producer of levulinic acid directly from biomass and at an industrial scale, has acquired the assets and intellectual property of Segetis, the main levulinic acid derivatives producer in the USA market.

Segetis brings unique knowhow and expertise, including more than 250 patents applications worldwide. The company has acquired Segetis’ production plant based in Minnesota and will establish a direct presence in the USA market under GFBiochemicals Americas.

Marcel van Berkel, Chief Commercial Officer of GFBiochemicals, commented: "Levulinic acid is one of the world’s most versatile building blocks for substituting oil-based products. With the acquisition of the Segetis assets and IP, including the Javelin brand of levulinic ketals technology, we can accelerate market entry for levulinic acid and its derivatives.”

Segetis is a premium levulinic acid derivatives producer with several proprietary applications – including fragrances, plasticisers for PVC & biopolymers, personal care, household & industrial cleaners, agrochemicals formulations and coating / adhesive strippers industries – coming from years of research and market development.

< Previous article

Hempel divests Blome subsidiary

Next article >

3M sells pressurised polyurethane foam adhesives business